SCHEDULE 13G: Vanguard Group Discloses 6.15% Stake in Arcellx Inc Common Stock
Beneficial Ownership Report (Schedule 13G)
The Vanguard Group has reported a 6.15% beneficial ownership stake in Arcellx Inc's common stock as of December 31, 2024, through a Schedule 13G filing with the SEC.
Summary
- The Vanguard Group, an investment adviser based in Pennsylvania, filed a Schedule 13G with the SEC regarding its ownership in Arcellx Inc.
- As of December 31, 2024, The Vanguard Group beneficially owned an aggregate of 3,330,092 shares of Arcellx Inc's common stock.
- This ownership represents 6.15% of the total class of Arcellx Inc's common stock.
- Vanguard holds sole voting power over 0 shares and shared voting power over 79,870 shares.
- Vanguard holds sole dispositive power over 3,216,296 shares and shared dispositive power over 113,796 shares.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Arcellx Inc.
Sentiment
Score: 6
Explanation: The document is a factual disclosure of institutional ownership. While a significant stake by Vanguard can be viewed positively by the market, the filing itself does not contain performance data or explicit sentiment regarding the company's operations.
Positives
- The disclosure of a significant 6.15% stake by a major institutional investor like The Vanguard Group can signal confidence or interest in Arcellx Inc, potentially attracting further investor attention.
Future Outlook
This Schedule 13G filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding Arcellx Inc's future performance or outlook.
Industry Context
The filing indicates a significant institutional investment in Arcellx Inc, which is common for publicly traded companies. Large institutional holdings by firms like Vanguard are a standard part of the market landscape, reflecting their investment strategies across various sectors.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake by The Vanguard Group may influence investor perception and potentially increase trading interest in Arcellx Inc's stock.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which required the filing of this statement (reporting period end date). |
| 01/30/2025 | Date the Schedule 13G statement was signed by The Vanguard Group. |
Keywords
Arcellx Inc, Vanguard Group, Schedule 13G, Common Stock, Institutional Ownership, Beneficial Ownership, SEC Filing, Investment Adviser
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.